C3 and metabolic dysfunction-associated steatotic liver disease: The meta-analysis results showed that serum C3 levels in the NAFLD population were significantly higher than those in the non-NAFLD population (MD: 0.43, 95% CI [0.26~0.60]) (I2 = 100%, P for heterogeneity <0.00001).